ARP | CEFS | ARP / CEFS | |
Gain YTD | 5.504 | 9.076 | 61% |
Net Assets | 42.4M | 297M | 14% |
Total Expense Ratio | 1.47 | 4.29 | 34% |
Turnover | 259.00 | 29.00 | 893% |
Yield | 5.06 | 7.90 | 64% |
Fund Existence | 3 years | 8 years | - |
ARP | CEFS | |
---|---|---|
RSI ODDS (%) | 5 days ago78% | 5 days ago75% |
Stochastic ODDS (%) | 5 days ago42% | 5 days ago73% |
Momentum ODDS (%) | 5 days ago88% | 5 days ago89% |
MACD ODDS (%) | 5 days ago83% | 5 days ago87% |
TrendWeek ODDS (%) | 5 days ago74% | 5 days ago89% |
TrendMonth ODDS (%) | 5 days ago73% | 5 days ago89% |
Advances ODDS (%) | 5 days ago75% | 5 days ago88% |
Declines ODDS (%) | N/A | N/A |
BollingerBands ODDS (%) | 5 days ago67% | 5 days ago72% |
Aroon ODDS (%) | 5 days ago69% | 5 days ago89% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MBCYX | 24.68 | 0.26 | +1.06% |
MassMutual Blue Chip Growth Svc | |||
GCSVX | 10.07 | 0.07 | +0.70% |
Geneva SMID Cap Growth Institutional | |||
FBSAX | 39.03 | 0.19 | +0.49% |
Franklin Mutual U.S. Mid Cap Value Adv | |||
THISX | 77.59 | 0.27 | +0.35% |
T. Rowe Price Health Sciences I | |||
WRAAX | 13.69 | 0.04 | +0.29% |
Wilmington Global Alpha Equities A |